Seres Therapeutics to Participate in Three Upcoming November Conferences
November 08 2017 - 4:00PM
Business Wire
Seres Therapeutics, Inc., (NASDAQ:MCRB) today announced that it
will participate in each of the following upcoming healthcare
conferences:
- Stifel 2017 Healthcare
Conference: A corporate overview will be presented on Tuesday,
November 14 at 5:00 p.m. ET in New York, NY.
- 29th Annual Piper
Jaffray Healthcare Conference: A corporate overview will be
presented on Wednesday, November 29 at 10:30 a.m. ET in New York,
NY.
- Evercore ISI Biopharma Catalyst/Deep
Dive Conference: Members of the management team will
participate in one-on-one meetings on Thursday, November 30 in
Boston, MA.
A live audio webcast of each presentation will be available
under the “Investors and Media” section of Seres’ website. A replay
of the presentation will become available approximately one hour
after the event and will be archived for 21 days.
About Seres Therapeutics
Seres Therapeutics, Inc., is a leading microbiome therapeutics
platform Company developing a novel class of biological drugs that
are designed to treat disease by restoring the function of a
dysbiotic microbiome, where the natural state of bacterial
diversity and function is imbalanced. Seres’ lead program, SER-109,
has obtained Breakthrough Therapy and Orphan Drug designations from
the U.S. Food and Drug Administration and is in Phase 3 development
for multiply recurrent C. difficile infection. Seres’ clinical
candidate SER-287 has successfully completed a Phase 1b study in
patients with mild-to-moderate Ulcerative Colitis. Seres is also
developing SER-262, the first ever synthetic microbiome therapeutic
candidate, in a Phase 1b study in patients with primary C.
difficile infection. For more information, please visit
www.serestherapeutics.com. Follow us on Twitter @SeresTx.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171108005134/en/
IR or PR Contact:Seres
TherapeuticsCarlo Tanzi, Ph.D., 617-203-3467Head of Investor
Relations and Corporate
Communicationsctanzi@serestherapeutics.com
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Apr 2023 to Apr 2024